Abstract
α-Catenin is an intracellular protein that associates with the carboxy-terminal region of cadherin, a cell adhesion molecule, via β-catenin or γ-catenin (plakoglobin). Linkage of cadherin to the cytoskeleton by catenins is required for full cadherin activity. Following transfection of an α-catenin-deficient colon carcinoma cell line with a series of α-catenin constructs, we discovered that the restoration of α-catenin expression results in reduced proliferation in three-dimensional multicellular spheroids, but not in two-dimensional monolayer cultures. The cellular function of α-catenin has not been compared between cells in three- and two-dimensional culture; this is the first evidence that growth regulation in three-dimensional cultures requires signaling mediated by α-catenin. Two classes of constructs, containing deletions in either the central segment or the COOH terminus of the molecule, both induced morphological changes, including cell compaction, and suppressed cell growth in three-dimensional cultures. In α-catenin-expressing cells, inhibition of cadherin cell adhesion by treatment with anti-E-cadherin antibodies resulted in a similar phenotype as that observed following the loss of α-catenin. Therefore, both the homophilic interaction of the cadherin extracellular domain and the linkage of the cadherin cytoplasmic domain to the actin cytoskeleton by α-catenin are necessary for growth control in three-dimensional culture.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH and Boyd MR . (1988). Cancer Res., 48, 589–601.
Anttila M, Kosma VM, Ji H, Wei-Ling X, Puolakka J, Juhola M, Saarikoski S and Syrjanen K . (1998). J. Clin. Oncol., 16, 2591–2600.
Bracke ME, Depypere H, Labit C, Van Marck V, Vennekens K, Vermeulen SJ, Maelfait I, Philippe J, Serreyn R and Mareel MM . (1997). Eur. J. Cell Biol., 74, 342–349.
Bullions LC, Notterman DA, Chung LS and Levine AJ . (1997). Mol. Cell. Biol., 17, 4501–4508.
Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oostuyse B, Dewerchin M, Zanetti A, Angellilo A, Mattot V, Nuyens D, Lutgens E, Clotman F, de Ruiter MC, Gittenberger-de Groot A, Poelmann R, Lupu F, Herbert JM, Collen D and Dejana E . (1999). Cell, 98, 147–157.
Espada J, Perez-Moreno M, Braga VM, Rodriguez-Viciana P and Cano A . (1999). J. Cell Biol., 146, 967–980.
Ewing CM, Ru N, Morton RA, Robinson JC, Wheelock MJ, Johnson KR, Barrett JC and Isaacs WB . (1995). Cancer Res., 55, 4813–4817.
Fukazawa H, Mizuno S and Uehara Y . (1995). Anal. Biochem., 228, 83–90.
Grazia Lampugnani M, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F, Orsenigo F, Cattelino A, Kemler R, Daniel TO and Dejana E . (2003). J. Cell Biol., 161, 793–804.
Harbour JW and Dean DC . (2000). Genes Dev., 14, 2393–2409.
Hengst L, Dulic V, Slingerland JM, Lees E and Reed SI . (1994). Proc. Natl. Acad. Sci. USA, 91, 5291–5295.
Hyafil F, Morello D, Babinet C and Jacob F . (1980). Cell, 21, 927–934.
Kantak SS and Kramer RH . (1998). J. Biol. Chem., 273, 16953–16961.
Kato A, Takahashi H, Takahashi Y and Matsushime H . (1997). J. Biol. Chem., 272, 8065–8070.
Kemler R, Babinet C, Heisen H and Jacob F . (1977). Proc. Natl. Acad. Sci. USA, 74, 4449–4452.
Kobayashi H, Man S, Graham CH, Kapitain SJ, Teicher BA and Kerbel RS . (1993). Proc. Natl. Acad. Sci. USA, 90, 3294–3298.
Laemmli UK . (1970). Nature, 227, 680–685.
Maeno Y, Moroi S, Nagashima H, Noda T, Shiozaki H, Monden M, Tsukita S and Nagafuchi A . (1999). Am. J. Pathol., 154, 1323–1328.
Matsubara S and Ozawa M . (2001). J. Cell Biol., 154, 573–584.
Morgan DO . (1995). Nature, 374, 131–134.
Muthuswamy SK, Li D, Lelievre S, Bissell MJ and Brugge JS . (2001). Nat. Cell Biol., 3, 785–792.
Nakopoulou L, Gakiopoulou-Givalou H, Karayiannakis AJ, Giannopoulou I, Keramopoulos A, Davaris P and Pignatelli M . (2002). Histopathology, 40, 536–546.
Obama H and Ozawa M . (1997). J. Biol. Chem., 272, 11017–11020.
Ohkubo T and Ozawa M . (1999). J Biol. Chem., 274, 21409–21415.
Ozawa M . (1998). J. Biol. Chem., 273, 29524–29529.
St Croix B, Sheehan C, Rak JW, Flrenes VA, Slingerlad JM and Kerbel RS . 1998. J. Cell Biol., 142, 557–571.
Pece S, Chiariello M, Murga C and Gutkind JS . (1999). J. Biol. Chem., 274, 19347–19351.
Polyak K, Kato J-Y, Solomon MJ, Sherr CJ, Massague J, Roberts JM and Koff A . (1994). Genes Dev., 8, 9–22.
Raftopoulos I, Davaris P, Karatzas G, Karayannacos P and Kouraklis G . (1998). J. Surg. Oncol., 68, 92–99.
Roe S, Koslov ER and Rimm DL . (1998). Cell Adhes. Commun., 5, 283–296.
Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava EM and Kosma VM . (1999). J. Clin. Pathol., 52, 10–16.
Shimazui T, Bringuier PP, van Berkel H, Ruijter E, Akaza H, Debruyne FM, Oosterwijk E and Schalken JA . (1997). Int. J. Cancer, 74, 523–528.
Slingerland JM, Hengst L, Pan C-H, Alexander D, Stampfer MR and Reed SI . (1994). Mol. Cell. Biol., 14, 3683–3694.
Surani MAH, Barton SC and Burling A . (1990). Exp. Cell Res., 125, 275–286.
Sutherland RM . (1988). Science, 240, 177–184.
Takeichi M . (1977). J. Cell Biol., 75, 464–474.
Teicher BA, Herman TS, Holden SA, Wang YY, Pfeffer MR, Crawford JW and Frei III E . (1990). Science, 247, 1457–1461.
Tran NL, Adams DG, Vaillancourt RR and Heimark RL . (2002). J. Biol. Chem., 277, 32905–32914.
Umbas R, Isaacs WB, Bringuier PP, Xue Y, Debruyne FM and Schalken JA . (1997). Int. J. Cancer, 74, 374–377.
Vasioukhin V, Bauer C, Degenstein L, Wise B and Fuchs E . (2001). Cell, 104, 605–617.
Vermeulen SJ, Bruyneel EA, Bracke ME, De Bruyne GK, Vennekens KM, Vleminckx KL, Berx GJ, van Roy FM and Mareel MM . (1995). Cancer Res., 55, 4722–4728.
Vestweber D and Kemler R . (1985). EMBO J., 4, 3393–3398.
Watabe M, Nagafuchi A, Tsukita S and Takeichi M . (1994). J. Cell Biol., 127, 247–256.
Watabe-Uchida M, Uchida N, Imamura Y, Nagafuchi A, Fujimoto K, Uemura T, Vermeulen S, van Roy F, Adamson ED and Takeichi M . (1998). J. Cell Biol., 142, 847–857.
Winston J, Dong F and Pledger WJ . (1996). J. Biol. Chem., 271, 11253–11260.
Woodfield RJ, Hodgkin MN, Akhtar N, Morse MA, Fuller KJ, Saqib K, Thompson NT and Wakelam MJ . (2001). Biochem. J., 360, 335–344.
Xiangming C, Hokita S, Natsugoe S, Tanabe G, Baba M, Takao S, Kuroshima K and Aikou T . (1999). Oncology, 57, 131–137.
Acknowledgements
We are grateful to Tamotsu Taniguchi for his help with these experiments and to Kumiko Sato for her administrative assistance. This work was supported by a Grant-in-Aid for Science Research on Priority Areas from the Ministry of Education, Science and Culture of Japan (B).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matsubara, S., Ozawa, M. Expression of α-catenin in α-catenin-deficient cells results in a reduced proliferation in three-dimensional multicellular spheroids but not in two-dimensional monolayer cultures. Oncogene 23, 2694–2702 (2004). https://doi.org/10.1038/sj.onc.1207423
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207423
Keywords
This article is cited by
-
Exclusion from spheroid formation identifies loss of essential cell-cell adhesion molecules in colon cancer cells
Scientific Reports (2018)
-
Loss of Coxsackie and adenovirus receptor downregulates α-catenin expression
British Journal of Cancer (2009)